Myoderm has expanded its portfolio to include distribution management services in an effort to provide clients with an efficient solution for sourcing, managing, and distributing off-the-shelf, commercial drugs used in clinical trials. According to the company, its distribution management service is an alternative to the current approach to site or patient reimbursement of commercially sourced drugs, and is designed to lower costs. The newly constructed distribution facilities features customized technology to support clinical supply planning, management, and sourcing.
Mike Cohen, Myoderm's managing director, foresees significant benefits for their clients, "With Distribution Management Services, our customers will be able to diminish logistical complexities, reduce exposure to waste, greatly improve traceability and control of their drug supplies, and more easily and cost-effectively achieve the time and cost benchmarks of their trials."
Sign up today for Contracting & Outsourcing 2009!